This company has great fundamentals. Price to Earnings: 1.88 & Earnings/Share (ttm): 2.01 Financial statements indicates positive income statements. Analysts target price is $4.00, Average trading volume is 2.00M +, so liquidity will not be an issue.
On the Technical aspect, it follows closely to weekly price trend. Trades in upper Bollinger Bands. Opens low and trends positively throughout each day. I made projections each day as I tracked it and left it unchanged. It appears to track nicely in an ABCD pattern overlay, currently breaking yearly resistance at $3.80. I suspect its positive fundamentals and FDA approvals in US and European H&S to be the driving forces.
Considering enter position at $3.80-3.85 or do so on the dip-buy 04/28/16 at open.
On the Technical aspect, it follows closely to weekly price trend. Trades in upper Bollinger Bands. Opens low and trends positively throughout each day. I made projections each day as I tracked it and left it unchanged. It appears to track nicely in an ABCD pattern overlay, currently breaking yearly resistance at $3.80. I suspect its positive fundamentals and FDA approvals in US and European H&S to be the driving forces.
Considering enter position at $3.80-3.85 or do so on the dip-buy 04/28/16 at open.
Commentaire:
finviz.com/quote.ashx?t=pdli
Commentaire:
Pre-market and Open tracked low today, hesitant all morning to jump in. Currently it sits the top slots of watchlist, if trendline strategy adheres, potential entry could be $3.75 to ride momentum.